Disease, Disability, and Injury Prevention and Control Special Emphasis Panel: Enhanced Surveillance for New Vaccine Preventable Disease, Funding Opportunity, 29501 [E7-10246]

Download as PDF Federal Register / Vol. 72, No. 102 / Tuesday, May 29, 2007 / Notices must provide a photo ID for entry into the meeting. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the designated contact person. Preregistration for public attendance is advisable and can be accomplished online by accessing the PACHA Web site https://www.pacha.gov. Members of the public will have the opportunity to provide comments at the meeting. Preregistration is required for public comment. Any individual who wishes to participate in the public comment session must register online at https://www.pacha.gov, registration for public comment will not be accepted by telephone. Public comment will be limited to five minutes per speaker. any members of the public who wish to have printed material distributed to PACHA members for discussion at the meeting should submit, at a minimum, one copy of the materials to the Executive Director, ACHA no later than close of business on June 8, 2007. Contact information for the PACHA Executive Director is listed above. Dated: May 22, 2007. Mary (Marty) McGeein, Executive Director, Presidential Advisory Council on HIV/AIDS. [FR Doc. 07–2609 Filed 5–25–07; 8:45 am] Centers for Disease Control and Prevention Task Force on Community Preventive Services sroberts on PROD1PC70 with NOTICES In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the following meeting: Name: Task Force on Community Preventive Services. Times and Dates: 8 a.m.–6 p.m. EDT, June 13, 2007; 8 a.m.–1 p.m. EDT, June 14, 2007. Place: Centers for Disease Control and Prevention, Roybal Building 19, 1600 Clifton Road, Atlanta, Georgia 30333. Status: Open to the public, limited only by the space available. Purpose: The mission of the Task Force is to develop and publish the Guide to Community Preventive Services (Community Guide), which consists of systematic reviews of the best available scientific evidence and associated recommendations regarding and what works in the delivery of essential public health services. Topics include: Excessive alcohol consumption; adolescent health; worksite health promotion; asthma; controlling Jkt 211001 Gynecologist Setting’’, and FOA IP07–009 ‘‘Impact of New Adolescent Vaccines on the Delivery of Recommended Clinical Preventive Services’’. Contact Person for More Information: Trudy Messmer, PhD, Designated Federal Official, 1600 Clifton Road, Mailstop C–19, Atlanta, GA 30333, telephone (404) 639– 2176. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: May 22, 2007. Elaine L. Baker, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E7–10246 Filed 5–25–07; 8:45 am] BILLING CODE 4163–18–P BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [Docket Number NIOSH–036] DEPARTMENT OF HEALTH AND HUMAN SERVICES 21:43 May 25, 2007 Dated: May 18, 2007. James D. Seligman, Chief Information Officer, Centers for Disease Control and Prevention. [FR Doc. E7–10217 Filed 5–25–07; 8:45 am] Disease, Disability, and Injury Prevention and Control Special Emphasis Panel: Enhanced Surveillance for New Vaccine Preventable Disease, Funding Opportunity BILLING CODE 4150–28–M VerDate Aug<31>2005 obesity; updating existing Community Guide reviews; and dissemination activities and projects in which the Community Guide is used. Agenda items are subject to change as priorities dictate. Persons interested in reserving a space for this meeting should call Tony Pearson-Clarke at 404.498.0972 by close of business on June 6, 2007. Contact Person for Additional Information: Tony Pearson-Clarke, Community Guide Branch, Coordinating Center for Health Information and Service, National Center for Health Marking, Division of Health Communication and Marketing, 1600 Clifton Road, M/S E–69, Atlanta, GA 30333, telephone: 404.498.0972. 29501 Announcement (FOA) IP07–001, Effectiveness of an Intervention to Promote Comprehensive Vaccination Programs in the ObstetricianGynecologist Setting, FOA IP07–008, and Impact of New Adolescent Vaccines on the Delivery of Recommended Clinical Preventive Services, FOA IP07– 009 In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces a meeting of the aforementioned Special Emphasis Panel. Time and Date: 12 p.m.–4 p.m., June 15, 2007 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters to be Discussed: The meeting will include the review, discussion, and evaluation of research grant applications in response to FOA IP07–001, ‘‘Enhanced Surveillance for New Vaccine Preventable Disease’’, FOA IP07–008 ‘‘Effectiveness of an Intervention to Promote Comprehensive Vaccination Programs in the Obstetrician- PO 00000 Frm 00020 Fmt 4703 Sfmt 4703 The National Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). AGENCY: ACTION: Notice of public meeting. Tuesday, June 26, 2007, opening session will begin at 9 a.m. EDT and the meeting will adjourn in mid-afternoon. Registration will be held from 8 a.m. to 9 a.m. MEETING DATE AND TIME: The Embassy Suites Pittsburgh International Airport, 550 Cherrington Parkway, Coraopolis, Pennsylvania 15108. SUMMARY: The NIOSH National Personal Protective Technology Laboratory (NPPTL) will hold a public meeting to discuss a proposed Total Inward Leakage (TIL) program for half-mask airpurifying particulate filtering respirator certification with plans to later include similar requirements for all respirator certifications. PLACE: PURPOSE: Recent trends in the field of personal protective equipment (PPE) testing have focused on the need to effectively evaluate PPE systems performance for TIL under laboratory conditions. While TIL testing performed under laboratory conditions does not necessarily reflect expected actual field level PPE performance, it does represent a criterion for performance that E:\FR\FM\29MYN1.SGM 29MYN1

Agencies

[Federal Register Volume 72, Number 102 (Tuesday, May 29, 2007)]
[Notices]
[Page 29501]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-10246]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel: Enhanced Surveillance for New Vaccine Preventable 
Disease, Funding Opportunity

    Announcement (FOA) IP07-001, Effectiveness of an Intervention to 
Promote Comprehensive Vaccination Programs in the Obstetrician-
Gynecologist Setting, FOA IP07-008, and Impact of New Adolescent 
Vaccines on the Delivery of Recommended Clinical Preventive Services, 
FOA IP07-009
    In accordance with section 10(a)(2) of the Federal Advisory
    Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces a meeting of the aforementioned Special 
Emphasis Panel.

    Time and Date: 12 p.m.-4 p.m., June 15, 2007 (Closed).
    Place: Teleconference.
    Status: The meeting will be closed to the public in accordance 
with provisions set forth in section 552b(c)(4) and (6), Title 5 
U.S.C., and the Determination of the Director, Management Analysis 
and Services Office, CDC, pursuant to Public Law 92-463.
    Matters to be Discussed: The meeting will include the review, 
discussion, and evaluation of research grant applications in 
response to FOA IP07-001, ``Enhanced Surveillance for New Vaccine 
Preventable Disease'', FOA IP07-008 ``Effectiveness of an 
Intervention to Promote Comprehensive Vaccination Programs in the 
Obstetrician-Gynecologist Setting'', and FOA IP07-009 ``Impact of 
New Adolescent Vaccines on the Delivery of Recommended Clinical 
Preventive Services''.
    Contact Person for More Information: Trudy Messmer, PhD, 
Designated Federal Official, 1600 Clifton Road, Mailstop C-19, 
Atlanta, GA 30333, telephone (404) 639-2176.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both CDC and the Agency for Toxic Substances and 
Disease Registry.

    Dated: May 22, 2007.
Elaine L. Baker,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention.
[FR Doc. E7-10246 Filed 5-25-07; 8:45 am]
BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.